Modular Medical, Inc. MODD
Medical/Dental Instruments · data as of November 13, 2026
Modular Medical, Inc. (MODD) is a healthcare company listed in the US with a market value of about $19M.
Its overall Stock Analiz score is 0.4 out of 5 (weak). The strongest part is financial health (2/5); the weakest is value (0/5).
Key numbers: a 5-year average ROIC of -129%.
About Modular Medical
Modular Medical is listed in the US and classified in medical/dental instruments. It was profitable in 0 of the last 10 years in our data. Its share count rose by 467% over three years (dilution for shareholders).
Score: 0.4 / 5
Checks passed
- More cash than debt, or low debt to equity
- Liabilities below 60% of assets
Checks not passed
- P/E below 25
- P/E below the industry median
- P/FCF below 20
- Price below intrinsic value (DCF, moderate assumptions)
- PEG below 1.5
- Revenue growth above 10% last year
- 3-year revenue growth above 10% a year
- Profit margin improving
Valuation
Growth and quality
Financials, last 10 years
| Fiscal year | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | — | — | — | — | — | — | — | — | $0 | $0 |
| Net income | -$28M | -$19M | -$17M | -$14M | -$19M | -$7M | -$5M | -$3M | -$659246 | -$106559 |
| Free cash flow | -$28M | -$18M | -$16M | -$13M | -$10M | -$6M | -$4M | -$2M | -$806250 | — |
| EPS (diluted) | $-12.36 | $-15.26 | $-23.41 | $-34.52 | $-82.24 | $-12.01 | $-9.00 | $-4.50 | $-1.47 | $-1.80 |
| Net margin | — | — | — | — | — | — | — | — | — | — |
| ROIC | -163.1% | -84.1% | -108.8% | -159.7% | -130.7% | — | -134.1% | -31.4% | -12.2% | -7.0% |
From the company’s 10-K and 10-Q filings with the SEC. TTM = trailing twelve months.
Frequently asked questions
Does Modular Medical pay a dividend?
Not currently.
Is Modular Medical a good stock to buy?
We do not give buy or sell advice. Modular Medical scores 0.4 out of 5 on our five checks (value, growth, track record, financial health and shareholder returns); the checks above show why.
Similar companies
Generated from SEC filings, analyst consensus estimates and market prices, rebuilt every day. Educational information, not investment advice.